Design Therapeutics, Inc. (DSGN)

Design Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Design Therapeutics stock has a target of 4.00, which predicts a 2.30% increase from the current stock price of 3.91.

Price Target: $4.00 (+2.30%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$4.00	$4.00	$4.00	$4.00
Change	+2.30%	+2.30%	+2.30%	+2.30%

* Price targets were last updated on Aug 6, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Design Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Mar '24	Apr '24	May '24	Jun '24	Jul '24	Aug '24
Strong Buy	0	0	0	0	0	0
Buy	0	0	1	1	1	0
Hold	4	4	3	3	3	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Leonid Timashev RBC Capital	RBC Capital	Hold Reiterates $4	Hold	Reiterates	$4	+2.30%	Aug 6, 2024
Yasmeen Rahimi Piper Sandler	Piper Sandler	Hold → Buy Upgrades $6 → $12	Hold → Buy	Upgrades	$6 → $12	+206.91%	May 7, 2024
Leonid Timashev RBC Capital	RBC Capital	Hold Reiterates $4	Hold	Reiterates	$4	+2.30%	Mar 20, 2024
Laura Chico Wedbush	Wedbush	Hold Reiterates $5	Hold	Reiterates	$5	+27.88%	Mar 20, 2024
Leonid Timashev RBC Capital	RBC Capital	Hold Maintains $7 → $4	Hold	Maintains	$7 → $4	+2.30%	Nov 14, 2023

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -1.36

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	226.00K	-	-	-	-	-	-	-
Revenue Growth	-72.90%	-	-	-	-	-	-	-
EPS	-0.52	-0.77	-1.14	-1.19	-0.88	-1.36	-1.26	-1.28
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.32	-0.89	-0.96
Avg	-1.36	-1.26	-1.28
Low	-1.40	-1.46	-1.57

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.